127 related articles for article (PubMed ID: 9840606)
1. Treatment of onchocerciasis with ivermectin (Province of Bururi, Burundi): parasitologic and clinical evaluation of different periodicities of treatment.
Vyungimana F; Newell E
Am J Trop Med Hyg; 1998 Nov; 59(5):828-31. PubMed ID: 9840606
[TBL] [Abstract][Full Text] [Related]
2. Effect of mass treatments with ivermectin, with only partial compliance, on prevalence and intensity of O. volvulus infection in adults and in untreated 4 and 5 year-old children in Burundi.
Newell ED
Trop Med Int Health; 1997 Sep; 2(9):912-6. PubMed ID: 9315050
[TBL] [Abstract][Full Text] [Related]
3. Adverse reactions to ivermectin treatment in Simulium neavei-transmitted onchocerciasis.
Kipp W; Bamhuhiiga J; Rubaale T; Büttner DW
Am J Trop Med Hyg; 2003 Dec; 69(6):621-3. PubMed ID: 14740878
[TBL] [Abstract][Full Text] [Related]
4. The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial.
Brieger WR; Awedoba AK; Eneanya CI; Hagan M; Ogbuagu KF; Okello DO; Ososanya OO; Ovuga EB; Noma M; Kale OO; Burnham GM; Remme JH
Trop Med Int Health; 1998 Dec; 3(12):951-61. PubMed ID: 9892280
[TBL] [Abstract][Full Text] [Related]
5. Ivermectin does not reduce the burden of itching in an onchocerciasis endemic community.
Whitworth JA; Luty AJ; Maude GH; Morgan D; Downham MD; Taylor DW
Trans R Soc Trop Med Hyg; 1992; 86(3):281-3. PubMed ID: 1412653
[TBL] [Abstract][Full Text] [Related]
6. [Onchocerciasis].
Takeuchi T
Ryoikibetsu Shokogun Shirizu; 1999; (24 Pt 2):455-7. PubMed ID: 10201255
[No Abstract] [Full Text] [Related]
7. The safety and efficacy of amocarzine in African onchocerciasis and the influence of ivermectin on the clinical and parasitological response to treatment.
Awadzi K; Opoku NO; Attah SK; Addy ET; Duke BO; Nyame PK; Kshirsagar NA
Ann Trop Med Parasitol; 1997 Apr; 91(3):281-96. PubMed ID: 9229021
[TBL] [Abstract][Full Text] [Related]
8. A community trial of ivermectin for onchocerciasis in Sierra Leone: clinical and parasitological responses to four doses given at six-monthly intervals.
Whitworth JA; Morgan D; Maude GH; Luty AJ; Taylor DW
Trans R Soc Trop Med Hyg; 1992; 86(3):277-80. PubMed ID: 1412652
[TBL] [Abstract][Full Text] [Related]
9. [Long-term effect of a single dose of ivermectin on skin microfilarial density in an endemic onchocerciasis area of North Cameroon].
Boussinesq M; Prod'hon J; Chippaux JP; Quillévéré D
Ann Soc Belg Med Trop; 1993 Sep; 73(3):189-96. PubMed ID: 8279866
[TBL] [Abstract][Full Text] [Related]
10. Community-based treatment of onchocerciasis with ivermectin in southwest Nigeria: dermatological response to a singledose therapy.
Osungbade KO; Asuzu MC; Kale OO
Afr J Med Med Sci; 2001 Dec; 30(4):352-5. PubMed ID: 14510119
[No Abstract] [Full Text] [Related]
11. Ivermectin treatment of onchocercal skin lesions: observations from a placebo-controlled, double-blind trial in Malawi.
Burnham G
Am J Trop Med Hyg; 1995 Mar; 52(3):270-6. PubMed ID: 7694970
[TBL] [Abstract][Full Text] [Related]
12. The effect of 5 years of annual treatment with ivermectin (Mectizan) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic.
Kennedy MH; Bertocchi I; Hopkins AD; Meredith SE
Ann Trop Med Parasitol; 2002 Apr; 96(3):297-307. PubMed ID: 12061976
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic image (82). A man with different leg colors. Onchocerciasis].
Verburg GP
Ned Tijdschr Geneeskd; 2002 Mar; 146(13):616. PubMed ID: 11957381
[TBL] [Abstract][Full Text] [Related]
14. After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues.
Katabarwa M; Eyamba A; Habomugisha P; Lakwo T; Ekobo S; Kamgno J; Kuete T; Ndyomugyenyi R; Onapa A; Salifou M; Ntep M; Richards FO
Trop Med Int Health; 2008 Sep; 13(9):1196-203. PubMed ID: 18631308
[TBL] [Abstract][Full Text] [Related]
15. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
[TBL] [Abstract][Full Text] [Related]
16. [Endemicity and clinical manifestations of onchocerciasis in the province of Bururi, Burundi].
Newell ED; Hicuburundi B; Ndimuruvugo N
Trop Med Int Health; 1997 Mar; 2(3):218-26. PubMed ID: 9491099
[TBL] [Abstract][Full Text] [Related]
17. [Onchodermatitis (sowda) in patients in Yémen. Clinical and histologic course after treatment with ivermectin].
al Qubati Y; Reynouard F; Kumar F; Gaxotte P; Richard-Lenoble D
Sante; 1997; 7(6):391-5. PubMed ID: 9503497
[TBL] [Abstract][Full Text] [Related]
18. Ivermectin treatment of hyperreactive onchodermatitis (sowda) in Liberia.
Darge K; Büttner DW
Trop Med Parasitol; 1995 Dec; 46(4):206-12. PubMed ID: 8826099
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects.
Albiez EJ; Newland HS; White AT; Kaiser A; Greene BM; Taylor HR; Büttner DW
Trop Med Parasitol; 1988 Mar; 39(1):19-24. PubMed ID: 3291074
[TBL] [Abstract][Full Text] [Related]
20. Ivermectin improves the skin condition and self-esteem of females with onchocerciasis: a report of two cases.
Amazigo UV; Nnoruka E; Maduka C; Bump J; Benton B; Sékétéli A
Ann Trop Med Parasitol; 2004 Jul; 98(5):533-7. PubMed ID: 15257804
[No Abstract] [Full Text] [Related]
[Next] [New Search]
